374 related articles for article (PubMed ID: 15545089)
1. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
Khan A; Benboubetra M; Sayyed PZ; Ng KW; Fox S; Beck G; Benter IF; Akhtar S
J Drug Target; 2004 Jul; 12(6):393-404. PubMed ID: 15545089
[TBL] [Abstract][Full Text] [Related]
2. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
Khan A; Sommer W; Fuxe K; Akhtar S
J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
[TBL] [Abstract][Full Text] [Related]
3. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
Lewis KJ; Irwin WJ; Akhtar S
J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer.
Hussain M; Beale G; Hughes M; Akhtar S
Int J Pharm; 2002 Mar; 234(1-2):129-38. PubMed ID: 11839444
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain.
Kilic AC; Capan Y; Vural I; Gursoy RN; Dalkara T; Cuine A; Hincal AA
J Microencapsul; 2005 Sep; 22(6):633-41. PubMed ID: 16401579
[TBL] [Abstract][Full Text] [Related]
7. SiRNA drug delivery by biodegradable polymeric nanoparticles.
Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
[TBL] [Abstract][Full Text] [Related]
8. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
[TBL] [Abstract][Full Text] [Related]
9. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
12. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP
Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
[TBL] [Abstract][Full Text] [Related]
13. Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides.
Jeong JH; Park TG
Bioconjug Chem; 2001; 12(6):917-23. PubMed ID: 11716682
[TBL] [Abstract][Full Text] [Related]
14. Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system.
Beale G; Hollins AJ; Benboubetra M; Sohail M; Fox SP; Benter I; Akhtar S
J Drug Target; 2003 Aug; 11(7):449-56. PubMed ID: 15203934
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
16. A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes.
De Rosa G; Bochot A; Quaglia F; Besnard M; Fattal E
Int J Pharm; 2003 Mar; 254(1):89-93. PubMed ID: 12615416
[TBL] [Abstract][Full Text] [Related]
17. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
[TBL] [Abstract][Full Text] [Related]
18. Design and characterisation of poly(lactide-co-glycolide) small particulate systems for the delivery of immunostimulant CpG oligonucleotide.
Shakweh M; Fattal E
J Nanosci Nanotechnol; 2006; 6(9-10):2811-20. PubMed ID: 17048487
[TBL] [Abstract][Full Text] [Related]
19. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
20. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]